Thrivent Financial for Lutherans’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $699K | Sell |
23,635
-53
| -0.2% | -$1.57K | ﹤0.01% | 1986 |
|
|
2025
Q1 | $707K | Sell |
23,688
-1,240
| -5% | -$37K | ﹤0.01% | 1921 |
|
|
2024
Q4 | $714K | Sell |
24,928
-369
| -1% | -$10.6K | ﹤0.01% | 2081 |
|
|
2024
Q3 | $977K | Sell |
25,297
-1,861
| -7% | -$71.9K | ﹤0.01% | 1930 |
|
|
2024
Q2 | $874K | Sell |
27,158
-1,133
| -4% | -$36.5K | ﹤0.01% | 1933 |
|
|
2024
Q1 | $1.1M | Sell |
28,291
-768
| -3% | -$29.8K | ﹤0.01% | 1857 |
|
|
2023
Q4 | $894K | Sell |
29,059
-2,716
| -9% | -$83.6K | ﹤0.01% | 1910 |
|
|
2023
Q3 | $710K | Sell |
31,775
-1,320
| -4% | -$29.5K | ﹤0.01% | 1949 |
|
|
2023
Q2 | $711K | Sell |
33,095
-175
| -0.5% | -$3.76K | ﹤0.01% | 2016 |
|
|
2023
Q1 | $798K | Sell |
33,270
-1,166
| -3% | -$28K | ﹤0.01% | 1916 |
|
|
2022
Q4 | $799K | Sell |
34,436
-841
| -2% | -$19.5K | ﹤0.01% | 1878 |
|
|
2022
Q3 | $565K | Buy |
35,277
+1,900
| +6% | +$30.4K | ﹤0.01% | 2018 |
|
|
2022
Q2 | $591K | Buy |
33,377
+5,235
| +19% | +$92.7K | ﹤0.01% | 2017 |
|
|
2022
Q1 | $573K | Buy |
28,142
+9
| +0% | +$183 | ﹤0.01% | 2130 |
|
|
2021
Q4 | $526K | Sell |
28,133
-614
| -2% | -$11.5K | ﹤0.01% | 2175 |
|
|
2021
Q3 | $567K | Sell |
28,747
-68
| -0.2% | -$1.34K | ﹤0.01% | 2134 |
|
|
2021
Q2 | $681K | Buy |
28,815
+264
| +0.9% | +$6.24K | ﹤0.01% | 2066 |
|
|
2021
Q1 | $677K | Buy |
+28,551
| New | +$677K | ﹤0.01% | 2090 |
|